We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Eicosapentaenoic acid at a dose of 4 g per day reduced ...
--Dosed first patient in Emerge, the first Phase 3 study of MM120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD); 12-week topline data anticipated in 2H 2026-- --Enrollment on ...
Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...
Mood symptoms alone do not account for the extent of disability associated with MDD. 12 Cognitive impairment, 1 of the 9 core symptoms of MDD (see Table 1), is significantly associated with impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results